Cassava Sciences | PTIE - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Abbott USD 6.8B 1.72B 2026-03
Amgen USD 12.04B 2.91B 2026-03
Biogen USD 3.38B 374.2M 2026-03
Cara Therapeutics USD 20.73M 684K 2025-12
Cassava Sciences USD 86.57M 8.93M 2026-03
Eisai JPY 301.65B 16.27B 2025-09
Eli Lilly USD 5.28B 1.99B 2026-03
Geron USD 68.9M 10.54M 2026-03
J&J USD 21.69B 1.98B 2026-03
Merck USD 5.33B 9.24B 2026-03
Novartis USD 6.88B 4.56B 2026-03
Novavax USD 228.36M 12.27M 2026-03
Pfizer USD 1.7B 561M 2026-03
Roche Holding CHF 7.55B 579M 2025-06